Current Controlled Trials in Cardiovascular Medicine
Công bố khoa học tiêu biểu
* Dữ liệu chỉ mang tính chất tham khảo
Sắp xếp:
Tamoxifen is not associated with increased CV event rate
Current Controlled Trials in Cardiovascular Medicine - Tập 2 - Trang 1-3 - 2001
Carotid intimal-media thickness as a surrogate for cardiovascular disease events in trials of HMG-CoA reductase inhibitors
Current Controlled Trials in Cardiovascular Medicine - Tập 6 - Trang 1-6 - 2005
Surrogate measures for cardiovascular disease events have the potential to increase greatly the efficiency of clinical trials. A leading candidate for such a surrogate is the progression of intima-media thickness (IMT) of the carotid artery; much experience has been gained with this endpoint in trials of HMG-CoA reductase inhibitors (statins). We examine two separate systems of criteria that have ......
Multi-drug risk reduction strategy safe in peripheral artery disease
Current Controlled Trials in Cardiovascular Medicine - - 2001
Long-term vitamin E supplementation fails to reduce lipid peroxidation in people at cardiovascular risk: analysis of underlying factors
Current Controlled Trials in Cardiovascular Medicine - Tập 3 Số 1 - 2002
Combining short stent implantation and drug-eluting stenting for routine use yields a low restenosis rate
Current Controlled Trials in Cardiovascular Medicine - Tập 6 - Trang 1-6 - 2005
Stent length serves as a predictor of restenosis in use of bare metal stents (BMS). This has been demonstrated in a feasibility study that used a single short BMS implant (<9 mm) in a high proportion of lesions; the study observed a low rate of restenosis. We performed a pilot prospective study to investigate in a series of consecutive patients the immediate and long-term effects of implantation o......
The current status of primary prevention in coronary heart disease
Current Controlled Trials in Cardiovascular Medicine - Tập 2 - Trang 1-14 - 2001
During the second part of the twentieth century, research advances caused a substantial decline in the rate of coronary heart disease. The decline lasted from the mid-1960s until the early 1990s and occurred primarily in Western countries. However, an unfavourable trend in coronary heart disease related mortality has gradually developed during the 1990s, with cardiovascular diseases anticipated to......
A Review of the Adverse Effects of Peripheral Alpha-1 Antagonists in Hypertension Therapy
Current Controlled Trials in Cardiovascular Medicine - Tập 3 - Trang 1-7 - 2002
Doxazosin and its role as an antihypertensive agent have come under recent scrutiny as a result of the early termination of that treatment arm in ALLHAT. It is unclear why the cardiovascular (CV) event rate in this randomized, controlled trial (RCT), especially heart failure, is higher in those treated with a doxazosin-based regimen than with a chlorthalidone based-regimen. There has been little w......
Diabetes and insulin use on AMI survival - is enough being done?
Current Controlled Trials in Cardiovascular Medicine - Tập 2 - Trang 1-3 - 2001
Debate: "How low should LDL cholesterol be lowered for optimum prevention of vascular disease?" Viewpoint: "Below 100 mg/dl"
Current Controlled Trials in Cardiovascular Medicine - Tập 2 - Trang 1-4 - 2001
Arteriosclerotic vascular disease manifests as heart disease, stroke, aortic aneurysms, and peripheral vascular disease, and is a growing problem world-wide. The preventive efforts made so far have demonstrated that lowering LDL-C is one action that individuals and populations can do with significant success in delaying the onset of clinical events. Epidemiological studies and small clinical trial......
Risk of intraparenchymal stroke increased by low saturated fat intake in women
Current Controlled Trials in Cardiovascular Medicine - Tập 2 - Trang 1-3 - 2001
Tổng số: 62
- 1
- 2
- 3
- 4
- 5
- 6
- 7